Is cannabis a treatment for glaucoma?

Medicinal cannabis is often presented as an alternative treatment for glaucoma. Although there is evidence that cannabis lowers intraocular pressure, its role as a viable glaucoma therapy is limited by a short duration of action, psychotropic effects, and possible tachyphylaxis.

Read more

RANZCO updates AMD referral pathway for optometrists

Professor Robyn Guymer has led an expert panel to update RANZCO’s Referral Pathway for Age-Related Macular Degeneration (AMD) Management, which accounts for greater accessibility to retinal imaging equipment and reminds clinicians to be aware of nearby clinical trials. Read more

Myopia Profile and CORE join forces

The world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed a new alliance with the renowned Centre for Ocular Research & Education (CORE). Read more

Campaign targets Aussies in their 50s at risk of AMD

Australian of the Year and ophthalmologist Dr James Muecke has endorsed a new campaign aimed at motivating Australians in their 50s to have a macula check after it was revealed most in this age group are unable to identify macular disease risk factors. Read more